FibroGen
FGEN
$1.04
Share price
1.96%
Change (1 day)
-93.93%
Change (1 year)
Categories
Operating Margin for FibroGen (FGEN)
Operating Margin as of April 2024 (TTM): -266.12%
According to FibroGen's latest financial reports and stock price the company's current Operating Margin is -266.12%. At the end of 2021 the company had an Operating Margin of -122.62%.
Operating Margin history for FibroGen from 2014 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -122.62% | 15.91% |
| 2020 | -105.79% | 267.97% |
| 2019 | -28.75% | -18.5% |
| 2018 | -35.28% | -61.84% |
| 2017 | -92.45% | 225.35% |
| 2016 | -28.41% | -31.04% |
| 2015 | -41.20% | 17.15% |
| 2014 | -35.17% | 747.31% |
| 2013 | -4.15% | -87.91% |
| 2012 | -34.35% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | -94.58% | -64.46% | 🇺🇸 USA |
 Acceleron Pharma XLRN | -226.57% | -14.86% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | -659.11% | 147.67% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.